BIO Asia–Taiwan 2021 亞洲生技大會

BIO Asia–Taiwan 2021 亞洲生技大會

講師

Flat Medical Co., Ltd. - TAcc+

Flat Medical Co., Ltd. - TAcc+

Company Info

Name /Flat Medical Co., Ltd. - TAcc+

Address /Rm. 1, 9F., No. 27, Sec. 1, Chang’an E. Rd., Taipei City 104, Taiwan

Website /www.flatmedical.com

Expecting startup year /

No. of team members /

Presenter

Name /Karl Tsao

Title /Executive Vice President

Email /karltsao@flatmedical.com

Telephone /(886) 225672959 #12

Fax /

Mobile /(886) 9886322871

Company Type

Device

About the Company

Flat Medical is a medtech company focusing on safety issues in clinical procedures. Its major product line, EpiFaith, is a safety solution for epidural, central line placement and many other blind puncture procedures, eliminating the potential adverse events lead by the risky procedure itself. Backed by medical KOLs and VCs across the globe, the company is commercializing it’s 1st product, a FDA-cleared/ CE marked innovation, in the U.S., several EU countries and Japan with leading partners in the territories.

Brief Description of main products or services

The 1st product, EpiFaith, is a safety solution for epidural anesthesia. By transforming the subjective tactile feeling into the objective visual signal, EpiFaith has been recognized as a reliable product for a safer localization into the epidural space. The clinical benefit of EpiFaith can be translated into substantial cost-reduction for the healthcare organizations. By ceasing the accidental dural puncture, additional admission time, additional blood patch procedure and the risk of permanent paralysis, EpiFaith can help decrease the extra medical cost of $56-93 (USD) averagely for each patient. The product is now in its early launch status, being trialed and early adopted in several renowned hospitals in the U.S. and Europe.

The same tech is now being applied to another critical care procedure, central venous catheterization. The second product on the pipeline, EpiFaith CV, is a visual indicator that helps intensivists identify the arrival of vein/ artery in an easy and reliable manner. With the auto-aspiration and pressure sensing mechanism inside, EpiFaith CV is changing the blindly-accesses procedure into a fast and accurate one. EpiFaith CV is now under the final review and expected to be CE-marked (MDR) and FDA cleared in Q4, 2021.

Contact Person

Name /Karl Tsao

Email /karltsao@flatmedical.com

Phone /(886) 225672959 #12